Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
| Publicado en: | European Radiology Vol. 33; no. 12; pp. 8669 - 8682 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173805889&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 173805889 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09387994 NPH jtl: European Radiology issn: 09387994 maglogo: N pubinfo: dt: Dec2023 vid: 33 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 173805889 164569229 10.1007/s00330-023-09754-2 173805889 ppf: 8669 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study. aug: au: Jin, Zhi-Cheng Zhong, Bin-Yan Chen, Jian-Jian Zhu, Hai-Dong Sun, Jun-Hui Yin, Guo-Wen Ge, Nai-Jian Luo, Biao Ding, Wen-Bin Li, Wen-Hui Chen, Li Wang, Yu-Qing Zhu, Xiao-Li Yang, Wei-Zhu Li, Hai-Liang Teng, Gao-Jun affil: https://ror.org/04ct4d772 Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, 210009, Nanjing, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|